A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma

Background. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with rapid tumor progression and poor prognosis. This study was motivated by the lack of sensitive and specific PDAC biomarkers and aimed to identify a diagnostic, serum protein signature for PDAC. Methods. To mimic a real...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerdtsson, Anna S., Malats, Núria, Säll, Anna, Real, Francisco X., Porta, Miquel, Skoog, Petter, Persson, Helena, Wingren, Christer, Borrebaeck, Carl A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637476/
https://www.ncbi.nlm.nih.gov/pubmed/26587286
http://dx.doi.org/10.1155/2015/587250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637476/
https://www.ncbi.nlm.nih.gov/pubmed/26587286
http://dx.doi.org/10.1155/2015/587250

Ejemplares similares